Celecoxib in Treating Patients With Early-Stage Rectal Cancer

NCT00608595 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Colorectal Cancer

Interventions

DRUG: celecoxib
GENETIC: gene expression analysis
GENETIC: protein expression analysis
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis
OTHER: mass spectrometry
PROCEDURE: biopsy
PROCEDURE: neoadjuvant therapy
PROCEDURE: therapeutic conventional surgery

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]